MX2008002294A - Derivados de pirimidina sustituida. - Google Patents
Derivados de pirimidina sustituida.Info
- Publication number
- MX2008002294A MX2008002294A MX2008002294A MX2008002294A MX2008002294A MX 2008002294 A MX2008002294 A MX 2008002294A MX 2008002294 A MX2008002294 A MX 2008002294A MX 2008002294 A MX2008002294 A MX 2008002294A MX 2008002294 A MX2008002294 A MX 2008002294A
- Authority
- MX
- Mexico
- Prior art keywords
- pyrimidine derivatives
- potassium channels
- kcnq potassium
- openers
- channels openers
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/50—Three nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200501262 | 2005-09-09 | ||
PCT/DK2006/050039 WO2007065449A1 (fr) | 2005-09-09 | 2006-09-07 | Derives de pyrimidine et leur emploi en tant qu'agents ouvrant les canaux potassiques kcnq |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2008002294A true MX2008002294A (es) | 2008-03-14 |
Family
ID=37199174
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2008002294A MX2008002294A (es) | 2005-09-09 | 2006-09-07 | Derivados de pirimidina sustituida. |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1937653A1 (fr) |
JP (1) | JP2009507052A (fr) |
KR (1) | KR20080043314A (fr) |
CN (1) | CN101258133A (fr) |
AR (1) | AR055420A1 (fr) |
AU (1) | AU2006322461A1 (fr) |
BR (1) | BRPI0615631A2 (fr) |
CA (1) | CA2621854A1 (fr) |
EA (1) | EA200800780A1 (fr) |
IL (1) | IL189545A0 (fr) |
MX (1) | MX2008002294A (fr) |
NO (1) | NO20081713L (fr) |
UA (1) | UA93387C2 (fr) |
WO (1) | WO2007065449A1 (fr) |
ZA (1) | ZA200802174B (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2008281112A1 (en) * | 2007-08-01 | 2009-02-05 | H. Lundbeck A/S | Use of KCNQ potassium channel openers for reducing symptoms of or treating disorders or conditions wherein the dopaminergic system is disrupted |
US7786146B2 (en) * | 2007-08-13 | 2010-08-31 | Valeant Pharmaceuticals International | Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators |
WO2010097379A1 (fr) * | 2009-02-24 | 2010-09-02 | Neurosearch A/S | Dérivés pyrimidine substitués et leur utilisation médicale |
JP5763758B2 (ja) * | 2010-07-08 | 2015-08-12 | ファイザー・インク | Kv7カリウムチャネル開口薬としてのピペリジニルピリミジンアミド |
NZ628871A (en) * | 2010-10-20 | 2015-07-31 | Gruenenthal Chemie | Substituted 6-amino-nicotinamides as kcnq2/3 modulators |
CN103508943B (zh) * | 2012-06-29 | 2017-06-09 | 江苏先声药业有限公司 | 作为钾通道调节剂的化合物 |
CN103508960B (zh) * | 2012-06-29 | 2017-12-12 | 江苏先声药业有限公司 | 苯并杂环衍生物 |
BR112017008178A2 (pt) * | 2014-10-24 | 2017-12-19 | Ono Pharmaceutical Co | ativador do canal de kcnq2-5 |
CN114206328A (zh) * | 2019-08-02 | 2022-03-18 | H.隆德贝克有限公司 | 用于在癫痫或癫痫发作中使用的作为Kv7钾通道开放剂的醇衍生物 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020183335A1 (en) * | 2001-02-20 | 2002-12-05 | Piyasena Hewawasam | 2, 4-disubstituted pyrimidine-5-carboxamide derivatives as KCNQ potassium channel modulators |
WO2003068769A1 (fr) * | 2002-02-12 | 2003-08-21 | Pfizer Inc. | Composes non-peptidiques influant sur l'action de la gnrh |
US20080261918A1 (en) * | 2004-12-17 | 2008-10-23 | Graham Andrew Showell | Silicon Compounds and Their Use |
-
2006
- 2006-09-07 UA UAA200803570A patent/UA93387C2/ru unknown
- 2006-09-07 EP EP06846967A patent/EP1937653A1/fr not_active Withdrawn
- 2006-09-07 MX MX2008002294A patent/MX2008002294A/es active IP Right Grant
- 2006-09-07 CN CNA2006800327125A patent/CN101258133A/zh active Pending
- 2006-09-07 ZA ZA200802174A patent/ZA200802174B/xx unknown
- 2006-09-07 BR BRPI0615631-2A patent/BRPI0615631A2/pt not_active IP Right Cessation
- 2006-09-07 CA CA002621854A patent/CA2621854A1/fr not_active Abandoned
- 2006-09-07 AU AU2006322461A patent/AU2006322461A1/en not_active Abandoned
- 2006-09-07 JP JP2008529473A patent/JP2009507052A/ja not_active Withdrawn
- 2006-09-07 EA EA200800780A patent/EA200800780A1/ru unknown
- 2006-09-07 KR KR1020087004306A patent/KR20080043314A/ko not_active Application Discontinuation
- 2006-09-07 WO PCT/DK2006/050039 patent/WO2007065449A1/fr active Application Filing
- 2006-09-08 AR ARP060103924A patent/AR055420A1/es not_active Application Discontinuation
-
2008
- 2008-02-14 IL IL189545A patent/IL189545A0/en unknown
- 2008-04-09 NO NO20081713A patent/NO20081713L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL189545A0 (en) | 2008-06-05 |
JP2009507052A (ja) | 2009-02-19 |
CA2621854A1 (fr) | 2007-06-14 |
NO20081713L (no) | 2008-06-04 |
ZA200802174B (en) | 2009-10-28 |
KR20080043314A (ko) | 2008-05-16 |
WO2007065449A1 (fr) | 2007-06-14 |
UA93387C2 (ru) | 2011-02-10 |
EA200800780A1 (ru) | 2008-06-30 |
AR055420A1 (es) | 2007-08-22 |
CN101258133A (zh) | 2008-09-03 |
EP1937653A1 (fr) | 2008-07-02 |
AU2006322461A1 (en) | 2007-06-14 |
BRPI0615631A2 (pt) | 2011-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2008002294A (es) | Derivados de pirimidina sustituida. | |
TW200800968A (en) | Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs | |
WO2007027238A3 (fr) | Inhibiteurs de kinase jak et utilisations de ceux-ci | |
TW200630367A (en) | Substituted adenines and the uses thereof | |
MX2010004576A (es) | Derivados de pirimidina novedosos. | |
SG164368A1 (en) | Treatment of cancer | |
WO2010090860A3 (fr) | Méthodes de traitement d'une infection bactérienne et compositions associées | |
TW200700064A (en) | Novel compounds | |
UA102251C2 (ru) | Производные аминодигидротиазина как ингибиторы васе для лечения болезни альцгеймера | |
TW200624426A (en) | BACE inhibitors | |
EA200970575A1 (ru) | Соединения на основе 4-фенил-6-(2,2,2-трифтор-1-фенилэтокси)пиримидина и способы их применения | |
UA85559C2 (en) | Aminobenzophenone compounds | |
WO2009077471A3 (fr) | Azolylméthyloxiranes, leur utilisation et agents les contenant | |
WO2006072612A3 (fr) | Triazolophthalazines | |
WO2007067559A3 (fr) | Agents antibacteriens | |
IL190730A0 (en) | Potassium channel inhibitors | |
UA90698C2 (en) | Triazole substituted aminobenzophenone compounds | |
MX2009013515A (es) | Derivados de 7-alquinil-1,8-naftiridonas, su preparacion y su aplicacion en terapeutica. | |
MX2009007713A (es) | Derivados de piridazina, procedimientos para su preparacion y su uso como fungicidas. | |
WO2007097981A3 (fr) | Alpha carbolines et leurs utilisations | |
MX2011005425A (es) | Derivados de carboxiamida lantibiotica con actividad antibacteriana mejorada. | |
WO2007120333A3 (fr) | Inhibiteurs de kinase tétracycliques | |
IL205696A0 (en) | Heterocyclic derivatives, compositions comprising the same and uses thereof | |
TW200726763A (en) | Novel compound | |
MX2010009276A (es) | Pirrolopirimidincarboxamidas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |